GlassScriptPhysician profile
Eric K Seaman
NPI 1548266414
$6,717.19
in general payments reported to CMS, 2019-2025
41 companies · $1,250 in 2025
The $1,250 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,299 · 2020: $557 · 2021: $1,229 · 2022: $429 · 2023: $1,290 · 2024: $663 · 2025: $1,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,202.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $942.34 | 2019-2025 | Rybrevant, Carvykti, Erleada |
| Myriad Genetic Laboratories, INC. | $690.93 | 2021-2025 | Myrisk, Prolaris |
| Coloplast Corp | $596.51 | 2019-2025 | Titan |
| Antares Pharma, INC. | $456.09 | 2019-2025 | Xyosted |
| Bayer Healthcare Pharmaceuticals INC. | $364.39 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $276.22 | 2021-2025 | Lynparza |
| Koelis INC. | $275.43 | 2021-2024 | |
| Astellas Pharma US INC | $244.69 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $238.39 | 2019-2023 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $217.89 | 2019-2021 | |
| Clarus Therapeutics INC. | $214.01 | 2021 | |
| Axonics, INC. | $194.94 | 2021-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $190.39 | 2019-2023 | |
| Progenics Pharmaceuticals, INC. | $147.42 | 2025 | |
| Olympus America INC. | $146.45 | 2025 | Itind System |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Seaman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.